Shannon Campbell
Board Member
Zentalis Pharmaceuticals, Inc. (ZNTL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Shannon Campbell
Shannon Campbell is recorded as Board Member at Zentalis Pharmaceuticals, Inc. (ZNTL). Zentalis Pharmaceuticals, Inc. reported in an 8-K filed May 27, 2026 that Shannon Campbell was appointed Class I director, effective May 22, 2026.
“Effective May 22, 2026, the Board of Directors (the "Board") of Zentalis Pharmaceuticals, Inc. (the "Company") increased its size from six to seven directors and appointed Shannon Campbell, as a Class I director.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-05-22–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Zentalis Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Julie Eastland CEO, Board Member
- Kimberly Blackwell, M.D. CEO
- David M. Johnson Chairman
- Scott Myers Chairman, Board Member
- Cam Gallagher CFO
- Vincent Vultaggio CFO, Chief Accounting Officer
- Iris Roth COO
- Iris Roth, Ph.D. COO
- James B. Bucher General Counsel
- David Johnson Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.